参考文献/References:
[1] ALELIGN T, AHMED M M, BOBOSHA K, et al.Kidney transplantation: the challenge of human leukocyte antigen and its therapeutic strategies [J]. Journal of Immunology Research, 2018, 2018:5986740.
[2] 杨小柯, 何柳媚, 全湛柔, 等.深圳地区人群乙型肝炎病毒携带者HLA-DRB1 等位基因多态性及关联性分析[J]. 现代检验医学杂志, 2020, 35(5): 5-8, 32.
YANG Xiaoke, HE Liumei, QUAN Zhanrou, et al.Analysis of allelic polymorphism and association of HLA-DRB1 in hepatitis B virus carriers in Shenzhen[J].Journal of Modern Laboratory Medicine, 2020, 35(5):5-8, 32.
[3] BORNI-DUVAL C, CAILLARD S, OLAGNE J, et al. Risk factors for BK virus infection in the era of therapeutic drug monitoring[J]. Transplantation, 2013,95(12): 1498-1505.
[4] SHENAGARI M , MONFARED A , EGHTEDARI H ,et al. BK virus replication in renal transplant recipients:Analysis of potential risk factors may contribute in reactivation[J]. Journal of Clinical Virology, 2017,96:7-11.
[5] DOGAN S E, CELEBI Z K, AKTURK S, et al.Prevalence and risk factors of BK viremia in patients with kidney transplantation: a Single-Center experience from Turkey[J]. Transplantation Proceedings, 2017,49(3): 532-536.
[6] MASUTANI K, NINOMIYA T, RANDHAWA P.
HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia[J]. Nephrology, Dialysis,Transplantation 2013, 28(12): 3119-3126.
[7] KAVUZLU M, BA?T?RK B, ATA? F B, et al.Investigation of the relationship between BK virus and human leukocyte antigens in kidney transplant recipients[J]. Experimental and Clinical Transplantation, 2020, 18(Suppl 1): 51-54.
[8] MINA M M, LUCIANI F, CAMERON B, et al.Resistance to hepatitis C virus: potential genetic and immunological determinants[J]. The Lancet Infectious Diseases, 2015, 15(4): 451-460.
[9] RAO Xiangyu, HOOF I, VAN BAARLE D , et al.HLA preferences for conserved epitopes : A potential mechanism for hepatitis C clearance[J]. Frontiers in Immunology, 2015, 6:552.
[10] WUNDERINK H F, HAASNOOT G W, DE BROUWER C S, et al. Reduced risk of BK polyomavirus infection in HLA-B51-positive Kidney Transplant Recipients[J]. Transplantation, 2019, 103(3):604-612.
[11] HIRSCH H H, KNOWLES W, DICKENMANN M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients[J]. The New England Journal of Medicine,2002, 347(7): 488-496.
[12] WADEI H M, RULE A D, LEWIN M, et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN)[J]. American Journal of Transplantation, 2006, 6(5 Pt 1): 1025-1032.
相似文献/References:
[1]杨小柯,何柳媚,全湛柔,等.深圳地区人群乙型肝炎病毒携带者HLA-DRB1 等位基因多态性及关联性分析[J].现代检验医学杂志,2020,35(05):5.[doi:10.3969/j.issn.1671-7414.2020.05.002]
YANG Xiao-ke,HE Liu-mei,QUAN Zhan-rou,et al.Analysis of Allelic Polymorphism and Association of HLA-DRB1 in Hepatitis
B Virus Carriers in Shenzhen[J].Journal of Modern Laboratory Medicine,2020,35(05):5.[doi:10.3969/j.issn.1671-7414.2020.05.002]